Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Many women undertreated for ovarian cancer

One in three ovarian cancer patients in the U.S. fails to receive the recommended comprehensive surgical treatment, according to a study in the May 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

9 Apr 2007

Almac announces study on colorectal pre-malignancies

Almac Diagnostics has announced a major study analysing colorectal polyp tissue samples using its novel Colorectal Cancer DSA microarray.

5 Apr 2007

Postmenopausal women encouraged to maintain regular health care

In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer.

2 Apr 2007

Protein podocalyxin changes the shape and adhesive quality of tumour cells

New non-toxic and targeted therapies for metastatic breast and ovarian cancers may now be possible, thanks to a discovery by a team of researchers at the University of British Columbia.

19 Mar 2007

Mayo Clinic tests engineered measles virus against multiple myeloma

Mayo Clinic Cancer Center has opened a new Phase I clinical trial testing an engineered measles virus against multiple myeloma, a cancer of the bone marrow that currently has no cure. This is the third of a series of molecular medicine studies in patients testing the potential of measles to kill cancer.

5 Mar 2007

Life-saving cancer genetic testing vastly underutilized

A study released today at the Society of Gynecologic Oncologists 38th Annual Meeting on Women's Cancer found few patients were aware of genetic cancer syndromes and the high risk of developing cancer if genetic mutations were found. Fewer still were motivated to follow up on this information with their own healthcare provider or genetic counseling/testing services.

5 Mar 2007

New understanding of how and why Taxol works in patients with breast cancer

Cancer researchers at Georgetown University Medical Center have taken a step towards understanding how and why a widely used chemotherapy drug works in patients with breast cancer.

22 Feb 2007

Women who donate eggs for stem cell research face few health risks

Women who donate their eggs for stem cell research or in vitro fertilization are not at increased risk of health complications, and most of the risks are a result of the hormones used to stimulate their bodies to release more than one egg, according to a report commissioned by the California Institute of Regenerative Medicine and released by the Institute of Medicine, Bloomberg reports.

13 Feb 2007

Risk of developing diabetes increasingly involved in decisions regarding HRT

Although doctors for years have "talked about the health effects of hormones on bones, breasts and women's hearts," diabetes has not been "part of the debate" until last week, when the North American Menopause Society in a revised position statement said that women taking hormone replacement therapy appear to be less likely to develop the disease, the Wall Street Journal reports.

7 Feb 2007

Selenium reduces prostate cancer risk in men taking extra vitamin E

A new study is suggesting that for certain groups of men a high dietary intake of selenium may reduce their risk of prostate cancer.

6 Feb 2007

Access Pharmaceuticals issued U.S. patent

This patent, entitled "O,O'-Amidomalonato and N,O-Amidomalonato Platinum Complexes" is one of a series of patents and patent applications owned by Access which provides intellectual property protection to ProLindac and related tumor-targeted platinum compounds.

30 Jan 2007

North American Menopause Society releases guidelines saying HRT beneficial for younger women

The North American Menopause Society on Thursday released a revised position statement that said the benefits of short-term hormone replacement therapy for treatment of menopausal women likely outweigh the risks for younger women, the Wall Street Journal reports.

28 Jan 2007

First year of cancer treatment costs patients $2.3 billion in lost time

The time that cancer patients nationwide spend when they travel to, wait for and receive inpatient and outpatient treatment costs an estimated $2.3 billion in the first year after diagnosis, according to a study published on Wednesday in the Journal of the National Cancer Institute, the AP/South Florida Sun-Sentinel reports.

7 Jan 2007

Mifepristone offers hope for breast cancer victims

A team of scientists have discovered some unexpected benefits with the abortion pill RU486 (Mifepristone).

4 Dec 2006

Medium-sized polyps yield significant number of advanced adenomas and cancer

According to a University of Pittsburgh-led study published in the December issue of Gastroenterology, medium-sized polyps found in the colon with flexible sigmoidoscopy and subsequently evaluated by full colonoscopy are associated with a significant number of advanced adenomas (high-risk polyps) and cancers.

2 Dec 2006

Muscle protein myosin VI involved in the development of prostate cancer

Researchers at the Johns Hopkins Kimmel Cancer Center have for the first time implicated the muscle protein myosin VI in the development of prostate cancer and its spread.

8 Nov 2006

Genomic test decides which drug is best for cancers

Scientists at Duke University, North Carolina have developed a panel of tests which are able to analyze a cancerous tumor and then decide which chemotherapy will most efficiently attack the cancer.

23 Oct 2006

An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling

Using a combination of enzyme activity and metabolite profiling, we determined that this protein-whose function was previously unknown-serves as a key regulator of a lipid signaling network that contributes to cancer," said Benjamin F. Cravatt, a Scripps Research professor and a member of its Skaggs Institute for Chemical Biology who led the study.

20 Oct 2006

Cisplatin nanoliposomes for cancer therapy

Cisplatin is one of the most powerful and effective drugs for treating a wide variety of cancers, but many tumors develop resistance to this drug, ultimately limiting its benefits for cancer patients.

19 Sep 2006

NIH to map genomic changes of lung, brain, and ovarian cancers

It is estimated that 174,470 new cases of lung cancer will be diagnosed in the United States in 2006. Lung cancer is the major cause of cancer-related mortality in both men and women, with an estimated 162,460 deaths expected to occur in 2006.

13 Sep 2006